Indegene IPO Details: Indegene’s upcoming IPO, slated for May 6 to May 8, aims to raise approximately ₹1841.76 crores. This offering includes a fresh issue of ₹760 crores and an offer for sale of up to 2,39,32,732 equity shares priced at ₹2 each.
Specializing in digital-led commercialization services for the life sciences sector, including biopharmaceuticals, emerging biotech, and medical devices, Indegene supports companies across various stages of drug development, regulatory compliance, and sales and marketing efforts. By leveraging their deep healthcare domain expertise and tailored technology solutions, they empower life sciences firms to efficiently develop, launch, and manage products throughout their lifecycle.
Indegene’s strong client base includes the world’s top 20 biopharmaceutical companies by revenue, contributing significantly to their revenue stream. As of December 31, 2023, they maintained active relationships with 65 clients, generating substantial revenue from a diverse range of clients, including those with whom they earned between US$0.25 million and US$25 million in revenues during the preceding 12 months.
This IPO signifies a milestone for Indegene, highlighting their market position and growth potential within the life sciences industry.
Indegene IPO Objectives:
The Company proposes to utilise the Net Proceeds towards funding the following objects:
- Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
- Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
- General corporate purposes and inorganic growth.
Indegene IPO Review (Apply or Not)
- Apply
Indegene IPO Date & Price Band Details:
| IPO Open: | 6-May-2024 |
| IPO Close: | 8-May-2024 |
| IPO Size: | Approx ₹1841.76 Crores |
| Fresh Issue: | Approx ₹760 Crores |
| Offer for Sale: | Approx ₹1081.76 Crores, 2,39,32,732 Equity shares |
| Face Value: | ₹2 Per Equity Share |
| IPO Price Band: | ₹430 to ₹452 Per Share |
| IPO Listing on: | BSE & NSE |
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| Discount: | N/A |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Indegene IPO Lot Size:
The minimum market lot for the Indegene IPO consists of 33 shares, requiring a minimum application amount of ₹14,916. Retail investors have the opportunity to apply for up to 13 lots, totaling 429 shares or an amount of ₹193,908.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 33 | ₹14,916 |
| Retail Maximum | 13 | 429 | ₹193,908 |
| S-HNI Minimum | 14 | 462 | ₹208,824 |
| B-HNI Minimum | 68 | 2,244 | ₹1,014,288 |
Indegene IPO Timeline:
The Indegene IPO is scheduled to open on May 6 and will close on May 8. The allocation of shares for the IPO will be finalized on May 9, with the listing on the stock exchange set for May 13.
This timeline provides investors with clear milestones for the IPO process, allowing for adequate planning and anticipation. It underscores Indegene’s commitment to transparency and adherence to a structured timeline for the benefit of all stakeholders involved.
| Anchor Investors Date: | May 5, 2024 |
| IPO Open Date: | May 6, 2024 |
| IPO Close Date: | May 8, 2024 |
| Basis of Allotment: | May 9, 2024 |
| Refunds: | May 10, 2024 |
| Credit to Demat Account: | May 10, 2024 |
| IPO Listing Date: | May 13, 2024 |
Indegene IPO GMP Today:
the last Grey Market Premium (GMP) for the Indegene IPO stands at ₹194. Considering the price band of ₹452.00, the estimated listing price for the IPO is projected to be ₹646 (comprising the cap price and today’s GMP). This suggests a potential gain or loss per share of approximately 42.92%.
These figures offer insights into the market sentiment surrounding the Indegene IPO, aiding investors in assessing potential returns and making informed decisions. It reflects the dynamics of market valuation and investor expectations, highlighting the anticipated performance of the IPO upon listing.
Indegene Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹996.92 | ₹768.25 | ₹149.41 |
| 2022 | ₹1690.50 | ₹1417.10 | ₹162.82 |
| 2023 | ₹2364.10 | ₹2001.05 | ₹266.10 |
| Dec 2023 | ₹1969.75 | ₹1644.64 | ₹241.90 |
Indegene IPO Valuation – FY2023
Check Indegene IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹12.03 per Equity Share |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 25.02% |
| Net Asset Value (NAV): | ₹48.10 per Equity Share |
Peer Group
- NA
Company Promoters
- The company is a professionally managed company and does not have an identifiable promoter.
Indegene IPO Registrar
Link Intime India Private Ltd
Phone: +91 81 0811 4949
Email: indegene.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Indegene IPO Allotment Status Check
Check Indegene IPO allotment status on Linkintime website allotment URL. Click Here
Indegene IPO Lead Managers aka Merchant Bankers
- Kotak Mahindra Capital Company Limited
- Citigroup Global Markets India Private Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory and Securities (India) Private Limited
Company Address
Indegene Limited
Aspen Block G4, 3rd Floor, Manyata Embassy Business Park,
Outer Ring Road, Nagawara, Bengaluru 560 045, Karnataka
Phone: +91 80 4674 4567
Email: compliance.officer@indegene.com
Website: www.indegene.com
